186
Views
8
CrossRef citations to date
0
Altmetric
Original

Dexa-BEAM as salvage therapy in patients with primary refractory aggressive Non-Hodgkin lymphoma

, , , , &
Pages 349-356 | Received 28 Feb 2006, Accepted 02 Jun 2006, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Niels Murawski, Carsten Zwick & Michael Pfreundschuh. (2010) Unresolved issues in diffuse large B-cell lymphomas. Expert Review of Anticancer Therapy 10:3, pages 387-402.
Read now

Articles from other publishers (7)

Kristin Gerhardt, Madlen Jentzsch, Thomas Georgi, Aleksandra Sretenović, Michael Cross, Enrica Bach, Astrid Monecke, Sabine Leiblein, Sandra Hoffmann, Milena Todorović, Jelena Bila, Osama Sabri, Sebastian Schwind, Georg-Nikolaus Franke, Uwe Platzbecker & Vladan Vučinić. (2021) Salvage Therapy With Polatuzumab Vedotin, Bendamustine, and Rituximab Prior to Allogeneic Hematopoietic Transplantation in Patients With Aggressive Lymphomas Relapsing After Therapy With Chimeric Antigen Receptor T-Cells—Report on Two Cases. Frontiers in Oncology 11.
Crossref
Clémentine Sarkozy & Bertrand Coiffier. (2015) Primary refractory diffuse large B cell lymphoma in the rituximab era. Current Opinion in Oncology 27:5, pages 377-383.
Crossref
Jan-Henrik Mikesch, Mareike Kuhlmann, Angela Demant, Utz Krug, Gabriela B. Thoennissen, Eva Schmidt, Torsten Kessler, Christoph Schliemann, Michele Pohlen, Michael Mohr, Georg Evers, Gabriele Köhler, Johannes Wessling, Rolf Mesters, Carsten Müller-Tidow, Wolfgang E. Berdel & Nils H. Thoennissen. (2013) DexaBEAM versus ICE salvage regimen prior to autologous transplantation for relapsed or refractory aggressive peripheral T cell lymphoma: a retrospective evaluation of parallel patient cohorts of one center. Annals of Hematology 92:8, pages 1041-1048.
Crossref
PAOLO G. GOBBI, LARA VILLANO, DONATELLA POZZOLI & MANUELA BERGONZI. (2010) Role of conventional salvage multiple-drug chemotherapy in relapsed and refractory aggressive non-Hodgkin lymphomas. Oncology Letters 1:4, pages 679-683.
Crossref
Carsten Zwick, Niels Murawski & Michael Pfreundschuh. (2010) Rituximab in High-Grade Lymphoma. Seminars in Hematology 47:2, pages 148-155.
Crossref
P G Gobbi, F Valentino, P Lambelet, V Perfetti, G Bergamaschi, M Girino & G R Corazza. (2009) Shortened and intensified MJMA: an effective salvage therapy for relapsed and refractory lymphomas and a strong mobilizer of PBSCs. Bone Marrow Transplantation 44:1, pages 19-25.
Crossref
. (2007) Current Awareness in Hematological Oncology. Hematological Oncology 25:4, pages 204-211.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.